The class includes several medications: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda)
Some fat loss occurs as a secondary benefit, but it is not the primary mechanism
It is not medical advice, not a therapeutic recommendation, and not instructions for human use
Nature 355(6359):441446 Zheng J-N, Zhuo J-Y, Nie J, Liu Y-L, Chen B-Y, Wu A-Z, Li Y-C (2021) Phenylethanoid glycosides from Callicarpa kwangtungensis Chun attenuate TNF--induced cell damage by inhibiting NF-B pathway and enhancing Nrf2 pathway in A549 cells
Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1